Role of Monocyte Chemoattractant Protein-1 in Various Pathological Conditions

单核细胞趋化蛋白-1 在各种病理条件下的作用

基本信息

  • 批准号:
    08457073
  • 负责人:
  • 金额:
    $ 3.9万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

Monocyte chemoattractant protein-1 (MCP-1) is one of the most potent chemoattractants for monocytes which belongs to the C-C chemokine group. In this project, we clarified the crucial role of MCP-1 in various pathological conditions in rats.1.Injection of recombinant rat MCP-1 into rat skin induced infiltration of TRPM-3-positive activated macrophages, whereas ED2-positive resident macrophages did not accumulate to the injection site.2.In rat models of pulmonary granulomatosis, we confirmed the expression of MCP-1 in the early phase of inflammation. Administration of nitric oxide synthase inhibitors significantly suppressed nitric oxide (NO) production and resulted in marked reduction monocyte/macrophage infiltration as well as in inhibition of MCP-1 production. These data indicate that NO may induce MCP-1 expression in lung granulomatosis.3.In collagen-induced rat arthritis, both MCP-1 concentration in the joint lavages and MCP-1 mRNA levels in the joint tissues at 2 weeks after the i … More mmunization of collagen. Injection of an anti-rat MCP-1 monoclonal antibody significantly decreased the number of exudate macrophages in the lesions and reduced the ankle swelling by about 30% compared with controls. These results suggest that MCP-1 plays a critical role in the recruitment of monocytes and in the development of rat arthritis.4.IN crescentic glomeruionephritis in rats, MCP-1 mRAN and proein are paralleled with the infiltration of monocyte/macrophages into glomeruli. MCP-1 mRNA was expressed intensely in the glomeruli 4days after the anti-glomerular basement membrane antibody injection. When MCP-1 was neutralized with anti-MCP-1 antibody administration, the number of monocyte/macrophage infiltrating in the glomeruli decreased by 34.7% and proteinuria by 66.4% at day 4. These data suggest that MCP-1 plays a crucial role in the glomerular accumulation of monocyte/macrophages and that the infiltrating monocyte/macrophages cause glomerular injury and increased excretion of protein in the urine. Less
单核细胞趋化蛋白-1(MCP-1)是C-C趋化因子家族中最强的趋化因子之一。本研究旨在阐明MCP-1在大鼠各种病理状态中的重要作用:1.将重组大鼠MCP-1注射到大鼠皮肤中,可诱导TRPM-3阳性的活化巨噬细胞浸润,而ED 2阳性的驻留巨噬细胞不聚集到注射部位; 2.在大鼠肺肉芽肿模型中,我们证实MCP-1在炎症早期表达。一氧化氮合酶抑制剂的管理显着抑制一氧化氮(NO)的生产,并导致显着减少单核细胞/巨噬细胞浸润,以及在MCP-1的生产抑制。提示NO可诱导肺肉芽肿组织中MCP-1的表达。3.在胶原诱导的大鼠关节炎模型中,NO诱导2周后,关节灌洗液中MCP-1的浓度和关节组织中MCP-1 mRNA的水平均显著高于对照组,但NO诱导2周后,关节灌洗液中MCP-1的浓度和关节组织中MCP-1 mRNA的水平均显著低于对照组,而NO诱导2周后,关节灌洗液中MCP-1的浓度和关节组织中MCP-1 mRNA的水平均显著高于对照组。 ...更多信息 胶原蛋白的免疫。与对照组相比,注射抗大鼠MCP-1单克隆抗体显著减少了病变中渗出巨噬细胞的数量,并使踝关节肿胀减少了约30%。这些结果表明MCP-1在单核细胞的募集和大鼠关节炎的发展中起关键作用。4.在大鼠新月体肾炎中,MCP-1 mRAN和蛋白与单核细胞/巨噬细胞向肾小球的浸润有关。注射抗肾小球基底膜抗体后4d,肾小球内MCP-1 mRNA表达增强。当MCP-1被抗MCP-1抗体中和时,肾小球中浸润的单核细胞/巨噬细胞的数量在第4天减少了34.7%,蛋白尿减少了66.4%。这些数据表明MCP-1在单核细胞/巨噬细胞的肾小球积累中起关键作用,并且浸润的单核细胞/巨噬细胞引起肾小球损伤和尿中蛋白质排泄增加。少

项目成果

期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamashiro S et al.: "Intradermal injection of monocyte chemoattractant protein-1 induces emigration and differentition of blood monocytes in rat skin" Int Arch Allergy Immunol. 115. 15-23 (1998)
Yamashiro S 等人:“皮内注射单核细胞趋化蛋白-1 诱导大鼠皮肤中血液单核细胞的迁移和分化”Int Arch Allergy Immunol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takeya M.et al: "Immunophenotypic characterization of macrophages migrate after intradermal injection of monocyte chemoattractant protein-1 (MCP-1) in rats." Acta Histochem Cytochem. 29. 208-209 (1996)
Takeya M.等人:“大鼠皮内注射单核细胞趋化蛋白-1 (MCP-1) 后巨噬细胞迁移的免疫表型特征。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamamoto T.et al: "Morphological alteration of cultured tracheobronchial epithelial cells is accompanied by the expression of chemokines, MCP-1 and CINC/gro, in rats." Int J Exp Pathol. (in press). (1998)
Yamamoto T.等人:“大鼠中培养的气管支气管上皮细胞的形态变化伴随着趋化因子 MCP-1 和 CINC/gro 的表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takeya M et al.: "Immunophenotypic characterization of macrophages migrated after intradermal injection of monocyte chemoattractant protein-1 (MCP-1) in rats" Acta Histochem Cytochem. 29(sup). 208-209 (1996)
Takeya M 等人:“大鼠皮内注射单核细胞趋化蛋白-1 (MCP-1) 后巨噬细胞迁移的免疫表型特征”Acta Histochem Cytochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Iyonaga K.et al: "A novel monoclonal antibody, RM-4, specifically recognizes rat macrophages and dendritic cells in formalin-fixed paraffin-embedded tissues" Histochem J. 29. 105-116 (1997)
Iyonaga K.等人:“一种新型单克隆抗体 RM-4,可特异性识别福尔马林固定石蜡包埋组织中的大鼠巨噬细胞和树突状细胞” Histochem J. 29. 105-116 (1997)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKEYA Motohiro其他文献

CD169+ macrophages in regional lymph nodes involved in the tumor immunity and prognosis in patients with colorectal cancer, melanoma and endometrial cancer.
区域淋巴结CD169巨噬细胞参与结直肠癌、黑色素瘤和子宫内膜癌患者的肿瘤免疫和预后。
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    OHNISHI Koji;KOMOHARA Yoshihiro;SAITO Yoichi;TAKEYA Motohiro
  • 通讯作者:
    TAKEYA Motohiro

TAKEYA Motohiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKEYA Motohiro', 18)}}的其他基金

Development of new therapeutic strategies for regulating macrophage activation by natural compounds
开发通过天然化合​​物调节巨噬细胞活化的新治疗策略
  • 批准号:
    23659204
  • 财政年份:
    2011
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
ROLE OF SCAVENGER RECEPTORS IN MACROPHAGE ACTIVATION AND THEIR APPLICATION FOR DIAGNOSIS AND THERAPY
清道夫受体在巨噬细胞激活中的作用及其在诊断和治疗中的应用
  • 批准号:
    20390113
  • 财政年份:
    2008
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Application of CD204 (scavenger receptor) to histopathological diagnosis and production of new anti-macrophage antibodies
CD204(清道夫受体)在组织病理学诊断和新型抗巨噬细胞抗体生产中的应用
  • 批准号:
    16390108
  • 财政年份:
    2004
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
IN VIVO EXPRESSION AND PATHOLOGICAL ROLES OF SCAVENGER RECEPTOR FAMILY MOLECULES
清道夫受体家族分子的体内表达和病理作用
  • 批准号:
    13470052
  • 财政年份:
    2001
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of scavenger receptors in atherogenesis and development of new therapeutic methods
清道夫受体在动脉粥样硬化形成中的作用和新治疗方法的开发
  • 批准号:
    12557023
  • 财政年份:
    2000
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Macrophage scavenger receptor as a new macrophage marker
巨噬细胞清道夫受体作为新的巨噬细胞标记物
  • 批准号:
    10470061
  • 财政年份:
    1998
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).

相似海外基金

PHASE 1 TRIAL FOR A THERAPEUTIC MONOCLONAL ANTIBODY FOR CHIKUNGUNYA VIRUS
基孔肯雅病毒治疗性单克隆抗体的第一阶段试验
  • 批准号:
    10892414
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
基本标题:预防临床前药理学和毒理学任务订单标题:使用人单克隆抗体 ATI-1013 进行尼古丁减少治疗
  • 批准号:
    10932479
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
  • 批准号:
    10674274
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
用于治疗马尔堡病毒病的单克隆抗体混合物
  • 批准号:
    10761372
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
  • 批准号:
    10711469
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
针对蚊子免疫细胞(针对疟疾)的表位定向单克隆抗体生产
  • 批准号:
    10933280
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
On-cell screening of mouse hybridomas for improved monoclonal antibody discovery
小鼠杂交瘤的细胞筛选以改进单克隆抗体的发现
  • 批准号:
    10696698
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Assessment of self-association of monoclonal antibody molecules by analysis of the protein layer detected at the proximity of a solid surface
通过分析在固体表面附近检测到的蛋白质层来评估单克隆抗体分子的自缔合
  • 批准号:
    10726173
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
STTR Phase I: Developing antifouling viral clearance membranes to enable efficient monoclonal antibody (mAb) processing
STTR 第一阶段:开发防污病毒清除膜以实现高效的单克隆抗体 (mAb) 处理
  • 批准号:
    2212947
  • 财政年份:
    2022
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Standard Grant
Development of transportable scFV monoclonal antibody into nucleus
可转运的scFV单克隆抗体进入细胞核的开发
  • 批准号:
    22K19387
  • 财政年份:
    2022
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了